Logo image of LUXE

LUXEXPERIENCE BV (LUXE) Stock Fundamental Analysis

NYSE:LUXE - New York Stock Exchange, Inc. - US55406W1036 - ADR - Currency: USD

9.4  +0.21 (+2.29%)

After market: 9.4 0 (0%)

Fundamental Rating

4

Overall LUXE gets a fundamental rating of 4 out of 10. We evaluated LUXE against 120 industry peers in the Specialty Retail industry. The financial health of LUXE is average, but there are quite some concerns on its profitability. LUXE is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year LUXE was profitable.
LUXE had a negative operating cash flow in the past year.
In the past 5 years LUXE reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: LUXE reported negative operating cash flow in multiple years.
LUXE Yearly Net Income VS EBIT VS OCF VS FCFLUXE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

1.2 Ratios

LUXE's Return On Assets of -5.01% is on the low side compared to the rest of the industry. LUXE is outperformed by 69.17% of its industry peers.
The Return On Equity of LUXE (-8.64%) is comparable to the rest of the industry.
LUXE has a Return On Invested Capital of 0.05%. This is in the lower half of the industry: LUXE underperforms 63.33% of its industry peers.
Industry RankSector Rank
ROA -5.01%
ROE -8.64%
ROIC 0.05%
ROA(3y)-2.35%
ROA(5y)-2.32%
ROE(3y)-3.64%
ROE(5y)-1.89%
ROIC(3y)N/A
ROIC(5y)N/A
LUXE Yearly ROA, ROE, ROICLUXE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

With a Operating Margin value of 0.03%, LUXE is not doing good in the industry: 63.33% of the companies in the same industry are doing better.
LUXE's Gross Margin of 47.04% is fine compared to the rest of the industry. LUXE outperforms 73.33% of its industry peers.
In the last couple of years the Gross Margin of LUXE has remained more or less at the same level.
Industry RankSector Rank
OM 0.03%
PM (TTM) N/A
GM 47.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.15%
LUXE Yearly Profit, Operating, Gross MarginsLUXE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LUXE is destroying value.
LUXE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, LUXE has less shares outstanding
LUXE has a better debt/assets ratio than last year.
LUXE Yearly Shares OutstandingLUXE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
LUXE Yearly Total Debt VS Total AssetsLUXE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

LUXE has an Altman-Z score of 4.62. This indicates that LUXE is financially healthy and has little risk of bankruptcy at the moment.
LUXE has a Altman-Z score of 4.62. This is amongst the best in the industry. LUXE outperforms 85.00% of its industry peers.
A Debt/Equity ratio of 0.19 indicates that LUXE is not too dependend on debt financing.
The Debt to Equity ratio of LUXE (0.19) is better than 61.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z 4.62
ROIC/WACC0.01
WACC7.19%
LUXE Yearly LT Debt VS Equity VS FCFLUXE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

LUXE has a Current Ratio of 1.78. This is a normal value and indicates that LUXE is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.78, LUXE is doing good in the industry, outperforming 75.83% of the companies in the same industry.
A Quick Ratio of 0.22 indicates that LUXE may have some problems paying its short term obligations.
The Quick ratio of LUXE (0.22) is worse than 86.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.22
LUXE Yearly Current Assets VS Current LiabilitesLUXE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 625.00% over the past year.
The Revenue has grown by 9.40% in the past year. This is quite good.
LUXE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.27% yearly.
EPS 1Y (TTM)625%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)9.4%
Revenue growth 3Y11.16%
Revenue growth 5Y17.27%
Sales Q2Q%3.68%

3.2 Future

The Earnings Per Share is expected to grow by 64.64% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 29.71% on average over the next years. This is a very strong growth
EPS Next Y274%
EPS Next 2Y108.21%
EPS Next 3Y64.64%
EPS Next 5YN/A
Revenue Next Year31.6%
Revenue Next 2Y56.86%
Revenue Next 3Y29.71%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LUXE Yearly Revenue VS EstimatesLUXE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
LUXE Yearly EPS VS EstimatesLUXE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4 0.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 28.48, LUXE can be considered very expensive at the moment.
LUXE's Price/Earnings is on the same level as the industry average.
LUXE is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.52, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 23.75, LUXE is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as LUXE.
When comparing the Price/Forward Earnings ratio of LUXE to the average of the S&P500 Index (22.25), we can say LUXE is valued inline with the index average.
Industry RankSector Rank
PE 28.48
Fwd PE 23.75
LUXE Price Earnings VS Forward Price EarningsLUXE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LUXE is valued a bit more expensive than the industry average as 69.17% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 59.92
LUXE Per share dataLUXE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

LUXE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LUXE's earnings are expected to grow with 64.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y108.21%
EPS Next 3Y64.64%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LUXE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LUXEXPERIENCE BV

NYSE:LUXE (6/6/2025, 8:05:42 PM)

After market: 9.4 0 (0%)

9.4

+0.21 (+2.29%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)09-10 2025-09-10/amc
Inst Owners20.93%
Inst Owner Change-5.09%
Ins Owners1.44%
Ins Owner ChangeN/A
Market Cap1.28B
Analysts76.36
Price Target12.07 (28.4%)
Short Float %4.1%
Short Ratio3.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)151.51%
Min EPS beat(2)96.08%
Max EPS beat(2)206.95%
EPS beat(4)2
Avg EPS beat(4)50.27%
Min EPS beat(4)-50.98%
Max EPS beat(4)206.95%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.32%
Min Revenue beat(2)-3.03%
Max Revenue beat(2)0.39%
Revenue beat(4)1
Avg Revenue beat(4)-2%
Min Revenue beat(4)-4.69%
Max Revenue beat(4)0.39%
Revenue beat(8)3
Avg Revenue beat(8)-1.04%
Revenue beat(12)4
Avg Revenue beat(12)-1.92%
Revenue beat(16)7
Avg Revenue beat(16)-0.76%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.35%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)20.68%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 28.48
Fwd PE 23.75
P/S 1.28
P/FCF N/A
P/OCF N/A
P/B 2.71
P/tB 4.33
EV/EBITDA 59.92
EPS(TTM)0.33
EY3.51%
EPS(NY)0.4
Fwd EY4.21%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS7.37
BVpS3.47
TBVpS2.17
PEG (NY)0.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.01%
ROE -8.64%
ROCE 0.06%
ROIC 0.05%
ROICexc 0.05%
ROICexgc 0.07%
OM 0.03%
PM (TTM) N/A
GM 47.04%
FCFM N/A
ROA(3y)-2.35%
ROA(5y)-2.32%
ROE(3y)-3.64%
ROE(5y)-1.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.15%
F-Score3
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA 4.11
Cap/Depr 47.13%
Cap/Sales 1.02%
Interest Coverage 0.05
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 0.22
Altman-Z 4.62
F-Score3
WACC7.19%
ROIC/WACC0.01
Cap/Depr(3y)134.72%
Cap/Depr(5y)94.09%
Cap/Sales(3y)2.03%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)625%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y274%
EPS Next 2Y108.21%
EPS Next 3Y64.64%
EPS Next 5YN/A
Revenue 1Y (TTM)9.4%
Revenue growth 3Y11.16%
Revenue growth 5Y17.27%
Sales Q2Q%3.68%
Revenue Next Year31.6%
Revenue Next 2Y56.86%
Revenue Next 3Y29.71%
Revenue Next 5YN/A
EBIT growth 1Y101.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year180.4%
EBIT Next 3Y47.61%
EBIT Next 5YN/A
FCF growth 1Y18.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-407.95%
OCF growth 3YN/A
OCF growth 5Y33.41%